JS Link Inc, formerly DNA Link Inc, is a Korea-based company mainly engaged in the genome analysis business. The Company mainly engages in the research and development of genome analysis services and personal genome analysis service products used for disease prevention, diagnosis, and treatment. The Company also mainly engages in the manufacture and sale of coronavirus disease 2019 (COVID-19) diagnostic kits. In addition, the Company engages in the research and development of â€˜Avatar Mouse,â€™ an anticancer drug efficacy evaluation system using the mouseâ€™s biological system.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
04/09/26	₩33,600.00	+12.37%	468,934
03/09/26	₩29,900.00	-2.61%	142,043
02/09/26	₩30,700.00	-4.06%	112,460
01/09/26	₩32,000.00	-3.03%	156,746
31/08/26	₩33,000.00	-2.80%	46,353

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 04/09/2026			5-day change	1st Jan Change
33,600.00 ^KRW	+12.37%		-1.18%	+88.24%

08-14	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI

Market Cap	1,168B 867M 746M 702M 641M 1.2B 81.86B 1.2B 8.3B 3.22B 42B 3.26B 3.18B 135B	P/E 2024	-10.5x	P/E 2025	-29.7x
Enterprise Value	1,171B 869M 748M 704M 643M 1.2B 82.07B 1.21B 8.32B 3.23B 42.11B 3.26B 3.19B 136B	EV / Sales 2024	8.93x	EV / Sales 2025	29.6x
Free-Float	71.99%	Yield 2024 *	-	Yield 2025	-

08-14	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI
07-07	REalloys Inc. and JS Link Inc. Sign Non-Binding Strategic Letter of Intent to Develop Fully Integrated North American Rare Earth Magnet Platform	CI
07-07	Australia's Lynas, South Korea's JS Link sign deal for Malaysia magnet factory	RE
07-07	Australia's Lynas signs deal with South Korea's JS Link to develop Malaysian magnet factory	RE
06-25	JS Link, Inc. announced that it has received KRW 30 billion in funding from Joosung Sea & Air Co. Ltd	CI
05-15	JS Link, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-13	JS Link, Inc. announced that it expects to receive KRW 5 billion in funding	CI
05-13	JS Link, Inc. announced that it expects to receive KRW 30 billion in funding	CI
03-23	JS Link, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-03	JS Link, Inc. announced that it has received KRW 20.00000805 billion in funding from Orbitech Co., Ltd., Joosung Sea & Air Co. Ltd	CI
11-14	JS Link, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-03	Malaysia PM says $142 million magnet plant to boost rare earth sector, state media reports	RE

1 day	+12.37%
1 week	-1.18%
Current month	+1.82%
1 month	+20.00%
3 months	-13.51%
6 months	-10.04%
Current year	+88.24%

JS Link, Inc. Stock

Stocks

A127120

KR7127120004

Biotechnology & Medical Research

Valuation : JS Link, Inc.

Chart: JS Link, Inc.

Latest news : JS Link, Inc.

Press Releases : JS Link, Inc.

Quotes and Performance

Price Extremes

Managers and Directors : JS Link, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	29,300	35,150
1 month	29,300	43,500
Current year	16,230	49,900
1 year	13,860	49,900
3 years	1,775	49,900
5 years	1,775	49,900
10 years	1,775	49,900

Manager	Title	Age	Since
Jun-Young Lee CEO	Chief Executive Officer	58	23/08/2024
Cheol-Gu Sim CEO	Chief Executive Officer	47	20/10/2023
Kenji Gonishi PRN	Corporate Officer/Principal	58	23/08/2024

Director	Title	Age	Since
Cheol-Gu Sim BRD	Director/Board Member	47	20/10/2023
Jun-Young Lee BRD	Director/Board Member	58	23/08/2024
Kenji Gonishi BRD	Director/Board Member	58	23/08/2024

Date	Insider	Type	Quantity	% Market Cap.
19/11/25	Jin-soo Park	Buy	1,500	0.0047%
17/11/25	Jin-soo Park	Buy	5,000	0.0157%
04/11/25	Jin-soo Park	Buy	87,138	0.2742%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JS LINK, INC.	+12.37%	-1.18%	+90.05%	+758.24%	765M
LONZA GROUP AG	-2.54%	-3.60%	-0.60%	+15.17%	50.35B
REVOLUTION MEDICINES, INC.	-0.40%	+1.03%	+439.20%	+523.39%	45.2B
IQVIA HOLDINGS INC.	-1.42%	+2.30%	+45.46%	+21.22%	44.71B
BEONE MEDICINES AG	-1.22%	-2.31%	+12.40%	+74.90%	41.24B
CELLTRION, INC.	+0.53%	-1.67%	+15.16%	+49.88%	33.08B
ASCENDIS PHARMA A/S	-0.21%	+9.14%	-	-	17.81B
MEDPACE HOLDINGS, INC.	-0.35%	-1.56%	+22.59%	+123.04%	16.56B
EUROFINS SCIENTIFIC SE	-1.01%	-0.38%	+15.69%	+28.39%	14.82B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.65%	-1.03%	+77.75%	+41.22%	14B
Average	+0.20%	+0.19%	+79.74%	+181.72%	27.85B
Weighted average by Cap.	-1.34%	-0.46%	+94.47%	+129.35%

	2024	2025
Net sales	15.91B 11.81M 10.16M 9.56M 8.74M 16.34M 1.12B 16.39M 113M 43.85M 572M 44.36M 43.39M 1.84B	19.32B 14.34M 12.34M 11.61M 10.61M 19.84M 1.35B 19.9M 137M 53.25M 695M 53.86M 52.69M 2.24B
Net income	-10.8B -8.02M -6.9M -6.49M -5.93M -11.1M -757M -11.13M -76.73M -29.78M -389M -30.12M -29.46M -1.25B	-16.45B -12.21M -10.51M -9.89M -9.03M -16.89M -1.15B -16.94M -117M -45.33M -592M -45.85M -44.85M -1.91B
Net Debt	14.39B 10.69M 9.2M 8.65M 7.9M 14.79M 1.01B 14.83M 102M 39.67M 518M 40.13M 39.26M 1.67B	2.88B 2.14M 1.84M 1.73M 1.58M 2.96M 202M 2.97M 20.47M 7.94M 104M 8.03M 7.86M 334M